Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/8/2017
SIETES contiene 91969 citas

 
 
 1 a 20 de 1113 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Dimmitt S, Stampfer H, Martin JH. When less is more – Efficacy with less toxicity at the ED50. Br J Clin Pharmacol 2017;83:1365-8. [Ref.ID 101984]
2. Cita con resumen
Kesselheim AS, Donneyong M, Dal Pan GJ, Zhou EH, Avorn J, Schneeweiss S, Seeger JD. Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications. Pharmacoepidemiol Drug Saf 2017;26:712-21. [Ref.ID 101627]
3. Cita con resumen
Finch A, Kubler P. The management of gout. Australian Prescriber 2016;39:1 de agosto. [Ref.ID 100572]
4. Cita con resumen
Anónimo. ‘Sí’ de la UE a un antipsicótico de Janssen de acción larga. Correo Farmacéutico 2016:17. [Ref.ID 100408]
5. Cita con resumen
Greene MF, Drazen JM. A new label for mifepristone. N Engl J Med 2016;374:2281-2. [Ref.ID 100400]
7.Tiene citas relacionadas Cita con resumen
Katz MH. Opioid prescribing for chronic pain. Not for the faint of heart . JAMA Intern Med 2016;176:599-601. [Ref.ID 100104]
8.Enlace a cita original Cita con resumen
Hayward KL, Powell EE, Irvine KM, Martin JH. Can paracetamol (acetaminophen) be administered to patients with liver impairment?. Br J Clin Pharmacol 2016;81:210-22. [Ref.ID 100097]
9. Cita con resumen
Cohen D. Rivaroxaban: can we trust the evidence?. BMJ 2016;352:i575. [Ref.ID 100048]
10.Enlace a cita originalTiene citas relacionadas Cita con resumen
Dowell D, Haegerich TM. CDC guideline for prescribing opioids for chronic pain — United States, 2016. JAMA 2016;315:15 de marzo. [Ref.ID 100030]
11. Cita con resumen
Anónimo. Thalidomide: reduced starting dose in patients older than age 75 years. Drug Safety Update 2015;9:2. [Ref.ID 99746]
12. Cita con resumen
Caverly TJ, Fagerlin A, Zikmund-Fisher BJ, Kirsh S, Kullgren JT, Prenovost K, Kerr EA. Appropriate prescribing for patients with diabetes at high risk for hypoglycemia. National Survey of Veterans Affairs health care professionals . JAMA Intern Med 2015;175:1994-6. [Ref.ID 99660]
13. Cita con resumen
Herman AO. FDA approves drug for hypoactive sexual desire disorder in women. Journal Watch 2015:1. [Ref.ID 99407]
14. Cita con resumen
Young K. FDA advisers back approval of first drug for female sexual dysfunction. Journal Watch 2015:1. [Ref.ID 99241]
15. Cita con resumen
Anónimo. FDA approves two drugs for treatment of IBS with diarrhea. DIA Daily 2015:28 de mayo. [Ref.ID 99106]
16. Cita con resumen
Limdi NA, Nolin TD, Booth SL, Centi A, Marques MB, Crowley MR, Allon M, Beasley TM. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study. Am J Kidney Dis 2015;65:701-9. [Ref.ID 99105]
17.Tiene citas relacionadas Cita con resumen
Keaney Jr JF. Balancing the risks and benefits of dual platelet inhibition. N Engl J Med 2015;372:1854-6. [Ref.ID 99087]
18.Tiene citas relacionadas Cita con resumen
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, for the PEGASUS-TIMI 54 Steering Committee and Investigators. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 2015;372:1791-800. [Ref.ID 99086]
19. Cita con resumen
Anónimo. Hydroxyzine (Atarax, Ucerax): risk of QT interval prolongation and torsade de pointes. Drug Safety Update 2015;8:1. [Ref.ID 99021]
20.Tiene citas relacionadas Cita con resumen
Sarrazin MSV, Rose A. Safety of new oral anticoagulants. BMJ 2015;350:h1679. [Ref.ID 98980]
Seleccionar todas
 
 1 a 20 de 1113 siguiente >>